What Brain Sentinel does

Brain Sentinel is a privately held, early-stage medical device company founded in 2011 and headquartered in San Antonio, Texas. The company develops AI-driven wearable technology aimed at detecting and predicting convulsive seizures in patients with epilepsy and other seizure disorders, with the stated objective of improving prediction accuracy and enhancing patient safety through early warning systems. The firm's go-to-market model, pricing, customer segments, and revenue mechanics are not disclosed in the available source material; the company is described as a start-up with a headcount range of 11–50 employees, indicating a small, pre-commercial or early-commercial operating footprint typical of a Class II/III medical device developer navigating regulatory pathways.

The broader market context — global AI-driven seizure prediction wearables projected to reach $3.87 billion by 2030 — positions Brain Sentinel within a high-growth addressable market in which it is identified as one of the key companies. However, the input data carries material operational uncertainty: the company's registered domain, brainsentinel.com, is no longer under apparent company control and currently hosts an unrelated Indonesian-language online gambling blog ("BLOG WAKWAW") with content dated August 2025. No funding rounds, partnerships, regulatory clearances, named customers, management team, product launch dates, or certification milestones are disclosed in the input data, which limits the depth of any forward-looking assessment.

Name

Brain Sentinel

Website

https://brainsentinel.com

Company type

Private

Founded year

2011

Headcount range

11–50 employees

Short description

Brain Sentinel is a privately held San Antonio–based medical device start-up, founded in 2011, that develops AI-driven wearable technology for convulsive seizure detection and prediction in patients with epilepsy and related seizure disorders.

Ownership category

akta.pro rank

Product category

Neurological Medical Devices

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industry

Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ)

Keywords

• Seizure detection devices
• Wearable medical devices
• Epilepsy monitoring systems
• Neurological diagnostic devices
• AI seizure prediction

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Core offering

Brain Sentinel is a medical device company that develops and sells a convulsive seizure detection device built on AI-driven wearable technology. The device is intended for patients with epilepsy or seizure disorders and functions as an early warning system to improve seizure prediction accuracy and patient safety.

Differentiator

Problem solved

Functional benefit

Products and services

• Convulsive Seizure Detection Device An AI-driven wearable medical device that detects convulsive seizures and provides early warning alerts to patients with epilepsy or seizure disorders and their caregivers, intended to improve patient safety through timely notification of seizure events outside clinical settings.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• NeuroPace: NeuroPace markets the RNS System, a closed-loop neurostimulation device for refractory epilepsy. It is a direct peer serving the same neurology patient base through implanted and wearable neurotechnology for seizure management.
• Empatica: Empatica develops the Embrace wearable, an FDA-cleared smartwatch for detecting generalized tonic-clonic seizures. It is the closest direct competitor to Brain Sentinel, targeting the same epilepsy patient population with AI-driven wearable seizure detection.

Emerging players

• Byteflies: Byteflies builds wearable EEG and biosensor platforms focused on neurology and sleep, including epilepsy monitoring pilots. It is an emerging player with partial overlap in wearable neuro-monitoring technology.
• Epitel: Epitel develops wearable EEG sensors and a cloud platform for continuous seizure monitoring in ambulatory settings. It is an emerging peer pursuing a similar AI-enabled ambulatory seizure-detection approach.

Broad incumbents

• Natus Medical: Natus Medical is a long-established provider of neurodiagnostic and neurology devices, including EEG equipment used in seizure detection and monitoring. It is a broad incumbent with overlapping end markets in hospital and ambulatory neurology.
• Medtronic: Medtronic operates a large neurosciences portfolio including DBS and intracranial diagnostics. It competes indirectly with Brain Sentinel in the broader neurological-device space and represents a formidable incumbent for any seizure-monitoring entrant.
• LivaNova: LivaNova is an established neuromodulation company whose VNS Therapy system is widely used for drug-resistant epilepsy. It is a broad incumbent competing in the same clinical indication with overlapping patient-safety value propositions.
• Cadwell Industries: Cadwell manufactures neurodiagnostic equipment including EEG systems used in epilepsy evaluation. It is a broad incumbent serving many of the same neurology clinical customers that Brain Sentinel's wearable device would target.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brain Sentinel